Transcatheter aortic valve replacement (TAVR) is now the dominant form of aortic valve replacement in the United States. Continued innovation has allowed the technique to be safe and democratized. New advances will increase the number of patients eligible to receive this therapy while increasing safety and efficiency. Herein, the authors review new TAVR technologies, approaches to valve deployment, and dedicated devices for cerebral embolic protection and vascular closure.
Keywords: Bicuspid aortic valve; Cerebral embolic protection; Innovation; TAVR; Vascular closure.
Copyright © 2021 Elsevier Inc. All rights reserved.